Watch the second video in our 2025 Year in Review series. This narrated slide deck, presented by Psychedelic Alpha Founder & Editor Josh Hardman, looks ahead to 2026. In this video, Hardman considers potential FDA approvals, Phase 3 readouts, alternative pathways to access, and more… This recording is exclusively for our Pα+ subscribers. Sign-in or join Pα+ to watch this video…

Source

Previous articleOli Genn-Bash: Functional Mushrooms, Hype Cycles, and Mycelial Thinking